• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

COVID-19 Vaccine 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for COVID-19 vaccine trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing COVID-19 vaccine research

COVID-19 has disrupted and transformed how vaccines are developed and delivered. Signant Health’s end-to-end clinical research solutions and scientific expertise deliver high-quality safety and efficacy data quickly and at-scale while reducing burdens on participants, sites, and sponsors.

Covid Vacine

Why Signant Health

  • Expedited clinical research, uncompromised data quality
  • Participant safety is paramount
  • Efficiency and accuracy at scale
  • Standard on-site, virtual, or hybrid - any trial model
  • Seize the data
  • Collect long-term efficacy and safety data in post-marketing
  • Expedited clinical research, uncompromised data quality

    Expedited clinical research, uncompromised data quality

    Take advantage of Signant’s experience with large-scale, multiphase, rapid COVID-19 vaccine studies. We leverage industry-pioneering evidence generation software solutions and internal clinical science, medicine, and global operational expertise to accelerate vaccine research without sacrificing data accuracy and reliability.
     

  • Participant safety is paramount

    Participant safety is paramount

    Mitigate risks to participants and study teams – our Signant SmartSignals eCOA solution reduces site visits and simplifies collection of primary safety data, while our Randomization and Trial Supply Management (RTSM) allows modifications study supply and distribution schemes to promote your primary endpoint and concern & safety.

     

     

  • Efficiency and accuracy at scale

    Efficiency and accuracy at scale

    COVID-19 vaccine studies require substantial participant populations, imposing numerous logistical complexities on sites. Signant SmartSignals eCOA, RTSM, and other study management solutions, supported by clinical and operational expertise, have been proven to help sites operate efficiently while improving data integrity in these large-scale, global vaccine studies.
     

  • Standard on-site, virtual, or hybrid - any trial model

    Standard on-site, virtual, or hybrid - any trial model

    COVID-19 has ushered in a new era of multi-modal clinical research. Whether your protocol requires in-person, virtual, or hybrid modes of conduct, Signant has the tools, flexibility, global reach, and clinical science expertise to bring trials to your participants.

  • Seize the data

    Seize the data

    Access your study data when and how you need it. With our data management services, you can collect, review, clean, and migrate clinical data as your protocol requires. From audit trail logs to change authorizations and database locks/archiving, our systems and services also facilitate seamlessly moving between study phases following adaptive design decision points.

  • Collect long-term efficacy and safety data in post-marketing

    Collect long-term efficacy and safety data in post-marketing

    Our secure and compliant Telemedicine solution replaces on-site visits with convenient video consultations, making it possible to reach a wider, more diverse patient population. The virtual platform allows study teams to frequently check in and communicate with patients.
     

Comprehensive Vaccine experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our COVID-19 Vaccine trial resources
SOLUTION BROCHURE

COVID-19 Vaccine Trial Solutions Overview


GET INSIGHTS
VIDEO

COVID-19 Vaccine Trial Solutions


WATCH [2 MIN]
SOLUTION

Vaccine Clinical Trial Solutions

 
LEARN MORE

eClinical solutions for COVID-19 vaccine trials

Ready to learn more?

Discover how Signant can support your current or upcoming COVID-19 trials. 

DOWNLOAD BROCHURE GET STARTED